Bank Of America Corp Inovio Pharmaceuticals, Inc. Transaction History

Bank Of America Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$0.35 - $0.53 $110,327 - $167,067	-315,222 Reduced 47.05%	354,738 $180,000
Q2 2023 Aug 14, 2023	SELL	$0.39 - $0.94 $1.11 Million - $2.68 Million	-2,850,667 Reduced 80.97%	669,960 $301,000
Q1 2023 May 12, 2023	BUY	$0.79 - $1.91 $829,634 - $2.01 Million	1,050,170 Added 42.51%	3,520,627 $2.89 Million
Q4 2022 Feb 10, 2023	BUY	$1.41 - $2.5 $1.11 Million - $1.98 Million	790,074 Added 47.02%	2,470,457 $3.85 Million
Q3 2022 Nov 14, 2022	BUY	$1.66 - $2.79 $1.1 Million - $1.85 Million	663,248 Added 65.21%	1,680,383 $2.9 Million
Q2 2022 Aug 12, 2022	SELL	$1.44 - $3.98 $624,098 - $1.72 Million	-433,402 Reduced 29.88%	1,017,135 $1.76 Million
Q1 2022 May 16, 2022	BUY	$2.97 - $5.2 $2.4 Million - $4.2 Million	807,638 Added 125.62%	1,450,537 $5.21 Million
Q4 2021 Feb 08, 2022	BUY	$4.99 - $7.46 $2.26 Million - $3.39 Million	453,780 Added 239.94%	642,899 $3.21 Million
Q3 2021 Nov 15, 2021	SELL	$7.16 - $9.69 $649,089 - $878,446	-90,655 Reduced 32.4%	189,119 $1.35 Million
Q2 2021 Sep 13, 2021	BUY	$6.23 - $10.03 $1.74 Million - $2.81 Million	279,774 New	279,774 $2.59 Million

281K

Ticker INO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 249,400,000
Market Cap $549M
Description
Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA se...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.